DNA Methylation Market

DNA Methylation Market Overview

The global DNA methylation market size, valued at USD 1.52 billion in 2024, is projected to reach USD 1.76 billion in 2025 and USD 6.12 billion by 2035, representing a CAGR of 13.2% during the forecast period.

To learn more about this report, request a free sample copy

DNA methylation is gaining rapid momentum due to its increasing applications, such as disease diagnosis, drug development, genomic research, and epigenetic research. Some of the reasons for instrumental growth include key role of DNA methylation in cancer detection, genetic disorders detection and increasing research on genomics for treating rare or un-diagnosed diseases.

DNA methylation represents an epigenetic mechanism in which a methyl group is added to the cytosine base specifically at CpG dinucleotides of DNA molecules. This methylation pattern can modulate gene expression without altering its base sequence, resulting in overexpression or suppression of gene function. DNA methylation plays a crucial role in genomic imprinting, gene regulation, and X-chromosome inactivation. Notably, DNA methylation analysis also helps in early disease diagnosis which is helpful to minimize the risk of complications and improve clinical outcomes.

It is worth noting that cancer and genetic disorders remain a significant burden on the healthcare industry. As stated in the National Cancer Institute report, in 2025, around 2,041,910 new cases of cancer will be diagnosed in the US and approximately 618,120 people will die from the disease. Some of the significant concerns associated with cancer are late diagnosis, and one-size treatment approach.

In order to mitigate the challenges, researchers are broadly adopting DNA methylation technologies, such as polymerase chain reaction, microarrays, and sequencing systems to understand the disease mechanism on genomic level and design tailored treatment to meet patient’s requirements.

Interestingly, the widespread adoption of DNA methylation technologies and broad emphasis on genome research have become crucial growth factors for this industry. It is worth noting that industrial players, such as Pfizer, Roche, QIAGEN are finding key opportunities in this field and focusing on technological innovations to make them more advanced and affordable. For instance, in April 2025, EpiCypher^® (a global leader in epigenomic innovation) launched CUTANA^® meCUT&RUN and Multiomic CUT&RUN (affordable methylation sequencing technologies) for drug discovery and genomic research.

Owing to the keen interest of industrial players, we believe that DNA methylation industry will remain competitive for a long term, offering plenty of opportunities for investments.

DNA Methylation Market: Report Attributes

Key Report Attributes	Details
Historical Trend	Since 2020
Forecast Period	Till 2035
Market Size 2025	USD 1.76 Billion
Market Size 2035	USD 6.12 Billion
CAGR (Till 2035)	13.2%

One of the key objectives of the DNA methylation market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.

The global market analysis report also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of technology, application area, end users, geographical regions, and leading players.

In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three DNA methylation market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.

Increasing adoption of technologies for early disease diagnosis has spurred the demand for DNA methylation analysis, which is expected to be a major driver for the market. Additionally, the expanding applications of DNA methylation beyond cancer diagnosis, and genomic analysis has offered a broad scope of innovation in this field to industrial players.

Recent Developments in DNA Methylation Market

Several recent developments have taken place in the field of DNA methylation, and we outline some of these below.

• In April 2025, PacBio has announced a significant enhancement to its HiFi sequencing technology by licensing advanced deep learning-based epigenetic models developed by Professor Dennis Lo and colleagues at The Chinese University of Hong Kong (CUHK) and Centre for Novostics. This new technology is designed to improve detection of important DNA base modifications—specifically, 5-hydroxymethylcytosine (5hmC), hemimethylated 5-methylcytosine (5mC), and N6-methyladenine (6mA) directly in native DNA, as part of standard HiFi whole-genome sequencing workflows.
• In April 2025, Agilent Technologies showcased its innovative products and Agilent Avida DNA Cancer Panels that enable simultaneous DNA methylation analysis and profiling from a single sample at the American Association for Cancer Research annual meeting held in April 2025 in Chicago, Illinois.
• In February 2025, Illumina revealed a series of roadmap innovations, establishing the largest portfolio of omics solutions, consumables, and sequencing applications. The solutions include spatial transcriptomics, spanning genomics, data analytics software, single cell analysis and DNA methylation analysis.

DNA Methylation Market Segmentation Insights

The market report provides comprehensive information on DNA methylation technology developers who are currently active across various segments of the industry as mentioned in the table below.

DNA Methylation Market: Market Segmentation

Market Segmentations	Details
Type of Technology	Polymerase Chain Reaction (PCR) Microarray Sequencing Others
Type of Product	Consumables Kits & Reagents Enzymes Instruments & Software
Application Area	Gene Therapy Clinical Research Diagnostics Others
End User	Hospital & Diagnostics Laboratories Pharmaceutical & Biotechnology Companies Research & Academia
Geographical Regions	North America Europe Asia-Pacific Middle East and North Africa Latin America
Market in North America	US Canada Mexico
Market in Europe	France Germany Italy Spain UK Rest of Europe
Market in Asia-Pacific	China India Japan South Korea Rest of the Asia-Pacific
Market in Middle East and North Africa	Egypt Saudi Arabia United Arab Emirates
Market in Latin America	Argentina Brazil

Industry Experts on DNA Methylation Market

DNA methylation editing tools and technologies holds great promise for advancing knowledge of gene regulation, disease detection and developing innovative drugs for addressing genetic and epigenetic disorders.

PacBio's President and CEO, Christian Henry, believes the DNA methylation market is key for advancement, especially with HiFi sequencing. “I am delighted to see this technology now being deployed more broadly through PacBio’s global customer base,” said Professor Dennis Lo, Scientific Director of Centre for Novostics, CUHK. “Accurate detection of DNA methylation—particularly 5mC and 5hmC—on native molecules is important for advancing research in cancer, human development, and beyond. With the improvements enabled by HK2, methylation calling with PacBio HiFi sequencing is poised to set a new standard for accuracy in the industry, surpassing other available technologies.”

DNA Methylation Market Share Insights

Market Share by Type of Technology

• Based on the type of technology, the global market is segmented into polymerase chain reaction (PCR), microarray, sequencing, and others. According to the DNA methylation market report, the present sequencing segment holds close to 40% of the market share. This can be attributed to the high adoption of sequencing technologies for DNA methylation analysis. Furthermore, bisulfite sequencing is a standardized technology which is widely used for epigenomic research and DNA methylation analysis.
• Notably, in the long run, sequencing and polymerase chain reaction segments are expected to register the fastest CAGR during the forecast period. This lucrative growth is due to the increasing usage of polymerase chain reaction technologies for DNA sequencing and analysis.
• It is worth mentioning that Key players, such as Illumina, QIAGEN, and Thermo Fisher Scientific are also focusing on the development of sequencing kits for DNA methylation analysis and polymerase chain reaction technologies.

Market Share by Type of Product

• The global market is categorized across different types of products, such as consumables, kits & reagents, enzymes, and instruments & software. Currently, kits & reagents segment hold 50% of the DNA methylation market share. DNA methylation kits specifically bisulfite sequencing kits are vital for preparing samples for DNA methylation analysis. Furthermore, industrial players are greatly encouraging the production of DNA methylation and sequencing kits for research purposes, which is expected to be a key driver for this segment.
• It is worth noting that the instruments & software segment is witnessing a substantial growth, anticipated registering a higher CAGR during the forecast period. This is primarily due to the increasing usage of next-generation sequencing technologies and software for DNA methylation analysis. Moreover, instruments & software offer higher flexibility and efficacy in the analysis of DNA methylation, which is expected to drive its demand in the future.

Market Share by Application Area

• The global market is further bifurcated based on application area into gene therapy, clinical research, diagnostics, and others. Based on our projection, presently the clinical research segment is holding 40.15% of the overall DNA methylation market share. This is likely to be the result of increasing adoption of sequencing technologies for DNA methylation analysis in research areas.
• Furthermore, growing research on epigenetics has further necessitated the demand for DNA methylation assays and sequencing technologies in research areas.
• Interestingly, diagnostic segment is likely to grow at a higher CAGR during the projected period. This unprecedented growth is due to the fact that DNA methylation technologies serve as an important tool for understanding diseases at genomic level and pathological diagnosis.

Market Share by End User

• The global market is categorized across different end users, such as hospital & diagnostics laboratories, pharmaceutical & biotechnology companies, and research & academia. Currently, pharmaceutical & biotechnology companies segment holds 49.43% share of the DNA methylation market size.
• Pharmaceutical & biotechnology companies are broadly using DNA methylation analysis technologies for drug discovery and development. Additionally, the growing emphasis on personalized therapies has further necessitated the demand for DNA methylation assays, kits, and sequencing technologies.
• Notably, the research & academia segment is expected to grow at a higher CAGR during the forecast period. Expanding research on epigenomics and growing emphasis on rare disease research are contributing to the lucrative growth of this segment.

Market Share by Geographical Regions

• The global market is distributed across North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. Among these regions, currently North America holds 40% share of the DNA methylation market size. Several factors, such as rising incidence of cancer, increasing research on epigenomics, and presence of established industrial players, such as Illumina, Pfizer and Thermo Fisher who are continually advancing sequencing technologies are driving growth of market in this region.
• In Asia-Pacific, the market for DNA methylation is expected to register a higher CAGR during the forecast period. Increasing research on cancer and genomic research are fueling the market growth in this region. Furthermore, rising government support for research on diseases and significant investments for technology upgradation are the key growth factors.

DNA Methylation Market: Report Deliverables

Report Deliverables	Details
Excel Data Packs (Complimentary)	Available
Key DNA Methylation Companies Profiled	Abcam (UK) Active Motif (US) Agilent Technologies (US) Bio-Rad Laboratories (US) Diagenode Diagnostics (Belgium) Exact Sciences (US) Illumina (US) New England Biolabs (US) QIAGEN (Germany) Roche (Switzerland) Sysmex (Japan) Thermo-Fisher Scientific (US) (A complete list of companies captured is available in the report)
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization

DNA Methylation Market Major Takeaways

The “DNA Methylation Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics, and future opportunities for DNA methylation industrial players. The market research report lays emphasis on the DNA methylation technologies that are being developed. Key takeaways of the market report are briefly discussed below.

How is DNA Methylation Market Competitive Landscape Fragmented?

With a broad focus on technological innovations for disease diagnosis and research, several industrial players are showing keen interest in this market. Overall, the market seems highly competitive, featuring the presence of several small, mid-sized and large industrial players.

Companies such as Abcam, Agilent Technologies, Bio-Rad, and Zymo Research are continually emphasizing the expansion of product portfolios, effective technologies innovations and investing heavily to develop cost-effective DNA methylation kits and instruments. Some of the notable products that are developed by industrial players for DNA methylation and are broadly accepted by the pharmaceutical companies, clinical research organizations and hospitals are mentioned below:

Leading Companies	Focus Area		Latest Technologies		Top Products
Abcam	Antibody And Assay Solutions		Methylation-Specific Antibodies		Anti-5-Methylcytosine Antibody
Active Motif	Epigenetics Research Tools		Antibody-Based Methylation Detection		Medip Kit
Illumina	NGS-Based Methylation Analysis		Infinium Methylation Arrays, NGS		Infinium Methylationepic Beadchip
New England Biolabs	Enzyme Solutions		Methylation-Sensitive Restriction Enzymes		EpiMark Methylated DNA Enrichment Kit
Thermo Fisher Scientific	PCR and Sequencing Solutions		Bisulfite Conversion, qPCR		Methylcode Bisulfite Conversion Kit
Qiagen	Sample Preparation and Analysis		Pyrosequencing, Bisulfite Conversion		EpiTect Bisulfite Kit
Zymo Research	Epigenetics Toolbox Provider		Bisulfite Conversion, Methylation-Specific PCR		EZ Dna Methylation Kit

 

What is the Current and Future Outlook for DNA Methylation Market?

The global market for DNA methylation is estimated to grow from USD 1.76 billion in 2025 to USD 6.12 billion by 2035, representing a CAGR of 13.2%. Large companies like New England Biolabs offer a range of reagents and consumables such as magnetic beads and primers for DNA methylation analysis. In addition, a number of epigenetic service providers provide DNA methylation analysis as part of their portfolios. The market for DNA methylation will continue to grow with the growing application of epigenetics.

What are the Key DNA Methylation Market Drivers?

The market for DNA methylation is propelled by several factors. Some of the notable factors are the rising prevalence of chronic diseases and genetic disorders across the globe. DNA methylation serves as an important biomarker for identifying epigenetic changes associated with these conditions, enabling early disease detection and improving patient outcomes.

Furthermore, the growing focus of industrial players to develop advanced high-throughput methods including microarrays and next-generation sequencing (NGS) has significantly facilitated genome-wide methylation profiling research. Additionally, the high demand for precision medicine has underscored the demand for DNA methylation analysis for the identification of biomarkers, early disease detection, risk assessment, and personalized treatment strategies, particularly in oncology and neurodegenerative diseases.

What are the Key Challenges in the DNA Methylation Market?

Despite promising growth prospects, the DNA methylation industry players face several significant challenges. Some of the noticeable challenges are technical complexities, data interpretation hurdles and lack of skilled personnel. It is worth mentioning that the uneven distribution of methylation target sequences may complicate the DNA methylation analysis process.

Furthermore, the complex nature of interpreting DNA methylation data presents substantial challenges, requiring multidisciplinary collaboration and continuous research efforts. In addition, the lack of qualified professionals for handling DNA methylation technologies may limit the adoption of new technologies across various industrial verticals.

What are the Top DNA Methylation Market Trends?

Despite significant challenges, the continuous adoption of DNA methylation analysis across research areas and healthcare industry is offering enormous opportunities to industrial players. Some of the notable trends of this industry includes expanding application beyond oncology, robust regulatory pathway, and cost reduction of genome sequencing.

While cancer applications have historically dominated the market, DNA methylation analysis is increasingly being applied to other areas including neurodegenerative disorders, cardiovascular diseases, metabolic disorders, and even aging research. The identification of age-associated CpG sites across diverse populations demonstrates the versatility of this technology.

Furthermore, the growing focus on cost reduction has made DNA methylation technologies more accessible to a broader range of research institutions, and healthcare providers. In addition, technological convergence like DNA methylation analysis with other omics technologies (genomics, proteomics, and transcriptomics) is creating more comprehensive biological insights. This multi-omics approach enhances our understanding of disease mechanisms and identifies novel therapeutic targets.

DNA Methylation Market Report Coverage

The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders in the DNA methylation industry, across different geographies. Amongst other elements, the market report includes:

• An Infographic Executive Summary
• Market Landscape of DNA Methylation Technology Developers
• Company Competitiveness Analysis
• Company Profiles
• SWOT Analysis
• Market Impact Analysis
• Market Forecast Analysis

From the Author’s Desk

Author’s View on DNA Methylation Market

The DNA methylation industry trajectory has been characterized by the increasing focus on epigenomics research, heightened demand for disease diagnosis and expanding clinical applications beyond oncology. Additionally, the acceptance of sequencing by regulatory authorities to accelerate the development of targeted therapies has underscored the demand for DNA methylation assay technologies. However, several challenges, such as data interpretation difficulties, and the requirement of skilled personnel remain a significant concern. In order to address these challenges, market players are leveraging partnerships and collaborations to develop affordable and easy to access sequencing technologies as well as kits, which further enhance competitiveness in this industry.

Glossary

• DNA Methylation: It refers to the biologic process during which a methyl group is added the C-5 position of DNA base or cytosine site. Methylation of DNA base can change the gene expression and suppress gene transcription, thereby suppressing gene function.
• Next-Generation Sequencing: It is a form of sequencing technologies that allow rapid sequencing of large amounts of DNA / RNA. Technology plays a significant role in disease diagnosis, genomic research, biomarkers identification and clinical applications.
• Polymerase Chain Reaction: It refers to the molecular biology technique which is used to create multiple copies of specific DNA fragment / sequence. This technology is broadly used in disease detection and gene amplification of genomic studies.